Agnieszka Boesen

Array ( [id] => 7061077 [patent_doc_number] => 20050003438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Conformational and topological protein regulation' [patent_app_type] => utility [patent_app_number] => 10/911421 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 26467 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003438.pdf [firstpage_image] =>[orig_patent_app_number] => 10911421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5770270 [patent_doc_number] => 20050266399 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'HCV regulated protein expression' [patent_app_type] => utility [patent_app_number] => 10/878556 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5868 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266399.pdf [firstpage_image] =>[orig_patent_app_number] => 10878556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589131 [patent_doc_number] => 08778671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus' [patent_app_type] => utility [patent_app_number] => 10/871775 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 13664 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10871775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705148 [patent_doc_number] => 20060194196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Novel surface protein (hbsag) variant of the hepatitis B virus' [patent_app_type] => utility [patent_app_number] => 10/561345 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12241 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194196.pdf [firstpage_image] =>[orig_patent_app_number] => 10561345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9354754 [patent_doc_number] => 08673285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Sphingoid polyalkylamine conjugates for vaccination' [patent_app_type] => utility [patent_app_number] => 10/560928 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 14 [patent_no_of_words] => 15200 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10560928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 439752 [patent_doc_number] => 07259246 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Immunological detection of prions' [patent_app_type] => utility [patent_app_number] => 10/867589 [patent_app_country] => US [patent_app_date] => 2004-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 12086 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259246.pdf [firstpage_image] =>[orig_patent_app_number] => 10867589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7202322 [patent_doc_number] => 20050042602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Monitoring immunologic, Hematologic and inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/866509 [patent_app_country] => US [patent_app_date] => 2004-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10024 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20050042602.pdf [firstpage_image] =>[orig_patent_app_number] => 10866509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642302 [patent_doc_number] => 20060280757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Flavivirus vaccine delivery system' [patent_app_type] => utility [patent_app_number] => 10/559146 [patent_app_country] => US [patent_app_date] => 2004-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14294 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280757.pdf [firstpage_image] =>[orig_patent_app_number] => 10559146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7256065 [patent_doc_number] => 20040259807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Monocyte locomotion inhibitory factor' [patent_app_type] => new [patent_app_number] => 10/861123 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4115 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20040259807.pdf [firstpage_image] =>[orig_patent_app_number] => 10861123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7126921 [patent_doc_number] => 20050058665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Identification of virulence determinants activators in prokaryotic pathogens' [patent_app_type] => utility [patent_app_number] => 10/860727 [patent_app_country] => US [patent_app_date] => 2004-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10995 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20050058665.pdf [firstpage_image] =>[orig_patent_app_number] => 10860727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040256 [patent_doc_number] => 20070092538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Immunogenic reagents from west nile virus' [patent_app_type] => utility [patent_app_number] => 10/557427 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 31406 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092538.pdf [firstpage_image] =>[orig_patent_app_number] => 10557427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4536110 [patent_doc_number] => RE041887 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-10-26 [patent_title] => 'Treatment of autoimmune disease' [patent_app_type] => reissue [patent_app_number] => 10/851983 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041887.pdf [firstpage_image] =>[orig_patent_app_number] => 10851983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056885 [patent_doc_number] => 20070059807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Mucosal immunization to prevent prion infection' [patent_app_type] => utility [patent_app_number] => 10/558276 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13932 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059807.pdf [firstpage_image] =>[orig_patent_app_number] => 10558276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7436196 [patent_doc_number] => 20040185061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Redox reversible HCV proteins with native-like conformation' [patent_app_type] => new [patent_app_number] => 10/825219 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17420 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185061.pdf [firstpage_image] =>[orig_patent_app_number] => 10825219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 867493 [patent_doc_number] => 07364744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-29 [patent_title] => 'Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV' [patent_app_type] => utility [patent_app_number] => 10/820816 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22421 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/364/07364744.pdf [firstpage_image] =>[orig_patent_app_number] => 10820816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7122367 [patent_doc_number] => 20050014196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Prion protein binding materials and methods of use' [patent_app_type] => utility [patent_app_number] => 10/817117 [patent_app_country] => US [patent_app_date] => 2004-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16012 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20050014196.pdf [firstpage_image] =>[orig_patent_app_number] => 10817117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204523 [patent_doc_number] => 20070026003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 10/550295 [patent_app_country] => US [patent_app_date] => 2004-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18554 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026003.pdf [firstpage_image] =>[orig_patent_app_number] => 10550295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7677631 [patent_doc_number] => 20040152195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Vector for introducing molecules in eukaryotic cells and molecules vectorised by same' [patent_app_type] => new [patent_app_number] => 10/466591 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6307 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152195.pdf [firstpage_image] =>[orig_patent_app_number] => 10466591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236429 [patent_doc_number] => 20070128586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Therapeutic, prophylactic and diagnostic agents' [patent_app_type] => utility [patent_app_number] => 10/550198 [patent_app_country] => US [patent_app_date] => 2004-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23927 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128586.pdf [firstpage_image] =>[orig_patent_app_number] => 10550198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918023 [patent_doc_number] => 20050095584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Method for determining early HCV seroconversion' [patent_app_type] => utility [patent_app_number] => 10/802891 [patent_app_country] => US [patent_app_date] => 2004-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5012 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20050095584.pdf [firstpage_image] =>[orig_patent_app_number] => 10802891 [rel_patent_id] =>[rel_patent_doc_number] =>)